In this podcast, ASCO Educational Book contributor Dr. Shilpa Grover, from Brigham and Women’s Hospital, describes GI and hepatic AEs encountered in patients on ICI therapy.
Shilpa Grover, MD, MPH
Advertisement
Articles by Shilpa Grover, MD, MPH
Advertisement
Latest Updated Articles
ASCO 2018 Highlights: GI and Hepatic Toxicities of Immune Checkpoint Inhibitor TherapyPublished: June 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era
2
Zipalertinib Yields Early Activity in EGFR+ NSCLC CNS Metastasis Population
3
CRT Does Not Improve RFS/OS, Confers High-Grade Toxicity in Cervical Cancer
4
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
5
